Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 45

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 45
---
 customer service, billing and systems processes, and expand internal quality assurance program and technology
to support operations on a larger scale. We will also need collaboration arrangements with third-party laboratories to process its physical
tests or, if processing of such tests is not fully outsourced to support demand, will need to obtain equipment and certified and licensed
laboratory personnel to process these physical tests internally. We may face difficulties increasing the scale of operations, including
implementing changes in infrastructure or programs or acquiring additional equipment or personnel. As we refine our products and develop
additional products, Renovaro Cube and BioSymetrics may need to introduce new equipment, implement new systems, technology, controls
and procedures, and hire personnel with different qualifications, licenses or certifications.

The value
of Renovaro Cube’s and BioSymetrics’ products will depend, in part, on our ability to perform tests, whether through a licensed
provider or internally, and return results to providers on a timely basis and at an appropriate quality standard, and on our reputation
for such timeliness and quality. Failure to establish necessary arrangements with licensed providers, to implement necessary procedures,
to transition to new equipment or processes, or to hire the appropriately qualified personnel could result in higher costs of processing,
longer turnaround times or an inability to meet market demand. There can be no assurance that Renovaro Cube, BioSymetrics, or any such
licensed provider will be able to perform tests on a timely basis at a level consistent with demand, that we will be able to maintain
the quality of our test results as we scale our commercial operations, or that we will be successful in responding to the potential growing
complexity of its operations, including the related data analysis requirements.

43

In addition,
Renovaro Cube’s and BioSymetrics’ growth may place a significant strain on its management, operating and financial systems,
research and development, and its sales, marketing, and administrative resources. As a result of growth, our operating costs may escalate
even faster than planned, and some of its internal systems may need to be enhanced or replaced. If Renovaro Cube or BioSymetrics cannot
effectively manage expanding operations and costs, Renovaro Cube or BioSymetrics may not be able to grow successfully or it may grow at
a slower pace, and its business could be adversely affected.

Renovaro
Cube and BioSymetrics will need to grow the size and capabilities of their organizations, and may experience difficulties in managing
this growth.

As of